Company Overview
Snapshot
Founded in September 2016 by Yenon Vashdi, Kaneh Bosem operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on expanding the therapeutic applications of cannabis.
Business overview
Kaneh Bosem is a startup in the Health Tech & Life Sciences sector, specifically within Pharma & Medical Biotechnology and Medical Cannabis. The company focuses on developing specific growing protocols and processing methods to create unique wide-spectrum formulas of organic cannabis extracts. These extracts aim to leverage the entourage effect of cannabis, combining THC, CBD, other cannabinoids, terpenes, and flavonoids to enhance therapeutic potential. Kaneh Bosem targets both B2B and B2C markets with its biotechnology and pharmaceutical offerings.
Company Intelligence Q&A
- What is Kaneh Bosem's primary focus in the cannabis industry?
- Kaneh Bosem aims to expand the therapeutic potential of cannabis by utilizing the entourage effect, which combines the main cannabinoids THC and CBD with other naturally occurring compounds in the plant.
- What is Kaneh Bosem's product development approach?
- The company develops specific growing protocols and processing methods to offer unique wide-spectrum formulas of organic cannabis extracts, which are validated through lab tests and analysis.
- When was Kaneh Bosem founded and by whom?
- Kaneh Bosem was founded in September 2016 by Yenon Vashdi.
- What business models does Kaneh Bosem employ?
- Kaneh Bosem operates with both B2B and B2C business models.
- What is Kaneh Bosem's status?
- Kaneh Bosem is currently non-active as of October 2018.